Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Pulmonology

  • Article

    Benefits of Triple Inhaler Therapy for Patients with Moderate to Severe Asthma

    December 1, 2022

    Dr. Magee Clinical Question: Does triple inhaler therapy improve outcomes over dual inhaler therapy in patients with moderate to severe asthma? Background: For patients with moderate and severe...

  • Article

    Using SMART Regimens in PHM

    September 23, 2022

    PHM Session: Get SMART: Implementation of updated asthma guidelines for pediatric hospitalists Presenters: Alexander Hogan, MD, MS, Connecticut Children’s Medical Center, Hartford, Conn., Kathryn...

  • Article

    Initiation of pulmonary rehabilitation after admission for COPD exacerbation decreases rehospitalizations

    August 1, 2022

    Ms. Langford Clinical question: Does the initiation of pulmonary rehabilitation after hospitalization for a chronic obstructive pulmonary disease (COPD) exacerbation impact...

  • Article

    Steroid Dosing, Surgery Outcomes for COVID-19 Patients, and More: Highlights from 2021 Research

    July 1, 2022

    Drs. Frank and Grant did an outstanding job with their in-person In the Literature at SHM Converge. Whether to use a standard or a personalized dose of corticosteroids in hospitalized patients...

  • Article

    Higher-than-expected recurrent VTE found in patients with isolated SSPE

    April 1, 2022

    Dr. Munoa Clinical question: What is the recurrence rate of venous thromboembolism (VTE) in patients with isolated subsegmental pulmonary embolisms (SSPE) managed without...

  • Article

    Active diagnostic strategy for pulmonary embolism in COPD exacerbations does not significantly alter a composite clinical outcome compared to usual care

    January 7, 2022

      Dr. Lublin Clinical question: Can an active diagnostic protocol including a D-dimer and computed tomography pulmonary angiogram (CTPA) for pulmonary emboli (PE) improve outcomes for...

  • News

    D-dimer thresholds rule out PE in meta-analysis

    December 14, 2021

    Data from a large review support use of D-dimer levels to diagnose PE without imaging.

  • 1
    News

    Apixaban outmatches rivaroxaban for VTE in study

    December 6, 2021

    These real-world findings may guide selection of initial anticoagulant therapy, according to authors of the paper.

  • 1
    News

    No serious CV risks for elderly after Pfizer COVID-19 vaccine

    December 2, 2021

    A French study adds to other evidence that the Pfizer mRNA COVID-19 vaccine does not increase the risk for serious cardiovascular adverse events in elderly individuals.

  • News

    Scientists ask whether Omicron can outrun Delta: How fast does it spread?

    November 29, 2021

    The fact that Omicron is already spreading in the presence of Delta, “which outcompeted all the other variants, is worrisome.”

Previous1 2 3 4 5 … 60Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences